Rapid Detection of Mobilized Colistin Resistance using a Nucleic Acid Based Lab-on-a-Chip Diagnostic System

Abstract

The increasing prevalence of antimicrobial resistance is a serious threat to global public health. One of the most concerning trends is the rapid spread of Carbapenemase-Producing Organisms (CPO), where colistin has become the last-resort antibiotic treatment. The emergence of colistin resistance, including the spread of mobilized colistin resistance (mcr) genes, raises the possibility of untreatable bacterial infections and motivates the development of improved diagnostics for the detection of colistin-resistant organisms. This work demonstrates a rapid response for detecting the most recently reported mcr gene, mcr−9, using a portable and affordable lab-on-a-chip (LoC) platform, offering a promising alternative to conventional laboratory-based instruments such as real-time PCR (qPCR). The platform combines semiconductor technology, for non-optical real-time DNA sensing, with a smartphone application for data acquisition, visualization and cloud connectivity. This technology is enabled by using loop-mediated isothermal amplification (LAMP) as the chemistry for targeted DNA detection, by virtue of its high sensitivity, specificity, yield, and manageable temperature requirements. Here, we have developed the first LAMP assay for mcr−9-showing high sensitivity (down to 100 genomic copies/reaction) and high specificity (no cross-reactivity with other mcr variants). This assay is demonstrated through supporting a hospital investigation where we analyzed nucleic acids extracted from 128 carbapenemase-producing bacteria isolated from clinical and screening samples and found that 41 carried mcr−9 (validated using whole genome sequencing). Average positive detection times were 6.58 ± 0.42 min when performing the experiments on a conventional qPCR instrument (n = 41). For validating the translation of the LAMP assay onto a LoC platform, a subset of the samples were tested (n = 20), showing average detection times of 6.83 ± 0.92 min for positive isolates (n = 14). All experiments detected mcr−9 in under 10 min, and both platforms showed no statistically significant difference (p-value > 0.05). When sample preparation and throughput capabilities are integrated within this LoC platform, the adoption of this technology for the rapid detection and surveillance of antimicrobial resistance genes will decrease the turnaround time for DNA detection and resistotyping, improving diagnostic capabilities, patient outcomes, and the management of infectious diseases. Antimicrobial resistance is a serious threat to global healthcare systems which poses a challenge for modern medicine and compromises effective infectious disease management. Of particular concern is the rapid spread of

A handheld point-of-care system for rapid detection of SARS-CoV-2 in under 20 minutes

“…29, the presented device is also a quantitative test, providing information on the viral load, which is an important indicator of the patient's infectivity. Furthermore, the proposed PoC diagnostic test can be rapidly adapted for the detection of other respiratory pathogens or infectious diseases (22)(23)(24) as only a target-specific LAMP assay has to be incorporated. This inherent capability promotes versatility and improves scalability, offering a wide range of applications that can be easily integrated for the simultaneous multiple detection of pathogens.…”

“…This represents a barrier to the implementation of portable devices for SARS-CoV-2 PoC diagnostics, which can be overcome by using label-free electrochemical-based DNA detection. Recently, in Rodriguez-Manzano et al (23), we reported an embedded Lab-on-Chip (LoC) device for label-free biosensing applications which consists of ion-sensitive fieldeffect transistors (ISFETs) manufactured in unmodified complementary metal-oxidesemiconductor (CMOS) technology (24). This device has integrated thermal management and is capable of nucleic acid detection by monitoring pH changes that occur during nucleic acid amplification which are compatible with isothermal assays.…”

Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings

“…27 Lab-on-chip, discs and cards can effectively bypass inadequate human resources, infrastructure and sometimes cold-chains. 28 The GeneXpert MTB/RIF platform is an example of one such leapfrog technology and the BioFire FilmArray represents another. The former has been more widely deployed in LMIC settings and consists of automated PCR system initially and most commonly used for tuberculosis diagnostics and rifampicin sensitivity testing.…”

Rapid Detection of Azole-Resistant Aspergillus fumigatus in Clinical and Environmental Isolates by Use of a Lab-on-a-Chip Diagnostic System

“…Recently, we have introduced a new smartphone-based lab-on-a-chip (LoC) platform, offering an affordable and portable alternative to gold-standard laboratory-based instruments for detection of infectious diseases (19). This platform combines ion-sensitive field-effect transistors (ISFETs), fabricated in unmodified complementary metal-oxide semiconductor (CMOS) technology, with loop-mediated isothermal amplification (LAMP) and an AndroidOS application for data acquisition, visualization and cloud connectivity.…”